|Home||» Products||» Pharmaceutical Tablet||» Daclinza 60mg - Daclatasvir 60mg Tablets|
Daclinza 60mg - Daclatasvir 60mg Tablets
Daclatasvir is indicated for use, with sofosbuvir, with or without ribavirin for the treatment of patients with chronic HCV genotype 1 or 3. The use of ribavirin depends on the patient population treated as outlined below. For patients with HCV/HIV-1 coinfection, the dosage and duration are the same as listed below.